Active surveillance for men with low-risk prostate cancer has made it to prime time. That was the message of Stacy Loeb, MD, who moderated a press conference at the AUA annual meeting, where four studies documented the increasing popularity and safety of active surveillance in managing low-risk disease.
Chemicals in green tea may help inhibit development of prostate cancer in men at high risk, according to results of a randomized, controlled trial.
An experimental assay could reduce the need for prostate needle biopsies, researchers say.
In a phase III study, a drug that blocks production of a protein was associated with a 27% reduction in the risk of death.
A study of patient outcomes 1 year after localized prostate cancer care seems to indicate that the answer is “no.”
A study of more than 300 men sheds new light on the prostate safety of testosterone replacement therapy.
Despite the benefit shown in this research, a study author says it’s too early to change practice.
This video describes a microsurgical, subinguinal, artery- and lymphatic-sparing technique of varicocelectomy.
A novel compound used with positron emission tomography imaging can identify foci of prostate cancer not found on biopsy of the prostate pre surgery or on the post-surgery specimen, according to a pilot study presented at the American Association of Cancer Research annual meeting in Philadelphia.
A large prospective study suggests men with male pattern baldness (MPB), particularly moderate MPB, are more likely to die from prostate cancer, compared to men with no MPB.
In this article, Robert A. Dowling, MD, examines some of the practice-related implications of the rapid change in the management of patients with advanced prostate cancer.
Other products featured include: Radiosurgery collimator allows treatment of broad rang of tumors and Phi prostate cancer test and more.
This video demonstrates a subinguinal microscopic varicocelectomy without delivery of the testis.
Most health information seekers navigate the Internet for what they think will be the best information available about their health condition or that of a loved one. Unfortunately, the Internet is unfiltered, unregulated, and often saturated with promotional, unsubstantiated, and at times frightening information.
This video demonstrates a technique for single-port laparoscopic varicocelectomy using both transperitoneal and preperitoneal approaches.
Patients taking to the Internet for information about testosterone replacement therapy are likely getting an incomplete picture of the potential risks and adverse effects linked with the treatment, say researchers from Northwestern University Feinberg School of Medicine, Chicago, and the University of Pennsylvania, Philadelphia.
Panelists and audience members at the recent AUA “crossfire” debate on focal therapy show why the treatment is so controversial.
The cell surface amino acid glypican-1 (GPC-1) represents a potential new biomarker for prostate cancer, said Jonathan Henderson, MD, at the AUA annual meeting.
A novel metric for evaluating post-prostatectomy outcomes could support quality improvement initiatives for optimizing patient recovery.
Recently published research on a novel chemotherapy-immunotherapy combination is “exciting for multiple reasons,” says one expert.
A new study assesses how a biopsy-based gene test impacts prostate cancer treatment recommendations in three high-volume practices.
Products in the pipeline for prostate cancer, bladder cancer, and much more.
Post-radical prostatectomy radiation therapy in patients at risk of prostate cancer recurrence is on the wane in the U.S., despite evidence and guidelines supporting the practice, recently published research indicates.
A patient follow-up report shows promising mid-term results from five German urology centers that implemented the prostatic urethral lift (UroLift System, NeoTract, Inc.) to alleviate symptomatic BPH in patients suffering from mild, moderate, and even severe obstruction.
Biomarker models to predict disease progression in prostate cancer have a promising future, but at present, they have not fully justified their claimed clinical utilities, according to the authors of an independent review and analysis of the literature.
